Quarterly Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7295281

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
83,817,000 JPY
16,920,000 JPY
Interest and dividends received
577,000 JPY
12,000 JPY
Interest paid
-1,756,000 JPY
-550,000 JPY
Income taxes paid
-5,859,000 JPY
-9,300,000 JPY
Net cash provided by (used in) operating activities
76,778,000 JPY
7,081,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-35,161,000 JPY
JPY
Other, net
0 JPY
178,000 JPY
Net cash provided by (used in) investing activities
-44,161,000 JPY
-8,821,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
10,000,000 JPY
Repayments of long-term borrowings
-41,667,000 JPY
-12,004,000 JPY
Net cash provided by (used in) financing activities
-38,857,000 JPY
2,996,000 JPY
Effect of exchange rate change on cash and cash equivalents
-3,067,000 JPY
2,820,000 JPY
Net increase (decrease) in cash and cash equivalents
-9,307,000 JPY
4,076,000 JPY
Cash and cash equivalents
665,662,000 JPY
674,969,000 JPY
566,074,000 JPY
561,997,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.